Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-011197

Chief Medical Officer sold 6,346 shares at $4.86 ($30,842)

  • Chief Medical Officer acquired 66,633 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ozden Rabia Gurses · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-03 Grant or award : show line 1 in the form +66,633 159,400 D
2024-02-05 Sale : show line 2 in the form +6,346 $4.86 $30,842 153,054 D
Open-market sales · 6,346 sh · avg $4.86 · $30,842

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-03 Grant or award : show line 3 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X05/tm245295-3_4seq1.xml…